BRIEF published on 05/28/2026 at 07:05, 2 months 26 days ago Sandoz Celebrates 80 Years of Antibiotics, Calls for European Policy Action Sandoz Group AG Antibiotic Production European Medicine Security Anti-dumping Complaint Public Health Policy
BRIEF published on 05/28/2026 at 07:05, 2 months 26 days ago Sandoz célèbre 80 ans d'antibiotiques et appelle à une action politique européenne. Groupe Sandoz AG Production D'antibiotiques Sécurité Des Médicaments En Europe Plainte Antidumping Politique De Santé Publique
BRIEF published on 05/28/2026 at 07:05, 2 months 26 days ago ASTA Energy Solutions AG Shows Strong Q1 2026 Performance Financial Performance Commercial Momentum ASTA Energy Solutions IPO Impact Q1 Results 2026
BRIEF published on 05/28/2026 at 07:05, 2 months 26 days ago ASTA Energy Solutions AG affiche de solides performances au premier trimestre 2026 Performance Financière Dynamique Commerciale Solutions Énergétiques ASTA Impact De L'introduction En Bourse Résultats Du 1er Trimestre 2026
BRIEF published on 05/28/2026 at 07:05, 2 months 26 days ago MPC Capital Reports 17% EBT Growth in Q1 2026 Revenue Decline Currency Effects EBT Growth Co-investment 2026 Outlook
BRIEF published on 05/28/2026 at 07:05, 2 months 26 days ago MPC Capital annonce une croissance de 17 % de son résultat avant impôt au premier trimestre 2026. Baisse Des Revenus Effets De Change Co-investissement Perspectives 2026 Croissance EBT
BRIEF published on 05/28/2026 at 07:05, 2 months 26 days ago MRM Health Secures €2.6M VLAIO Grant for Inflammatory Disease Research Inflammatory Diseases VLAIO Grant MRM Health Microbiome Research Live Biotherapeutic Products
BRIEF published on 05/28/2026 at 07:05, 2 months 26 days ago MRM Health obtient une subvention de 2,6 millions d'euros du VLAIO pour la recherche sur les maladies inflammatoires Maladies Inflammatoires MRM Santé Subvention VLAIO Recherche Sur Le Microbiome Produits Biothérapeutiques Vivants
BRIEF published on 05/28/2026 at 07:05, 2 months 26 days ago Sanofi's Venglustat Granted Priority Review for Type 3 Gaucher Disease Sanofi FDA Review Venglustat Gaucher Disease Neurological Treatment
BRIEF published on 05/28/2026 at 07:05, 2 months 26 days ago Le venglustat de Sanofi obtient un examen prioritaire pour la maladie de Gaucher de type 3 Sanofi Examen De La FDA Venglustat Maladie De Gaucher Traitement Neurologique
Published on 08/22/2026 at 05:50, 1 day 10 hours ago Battery X Metals Provides Board of Directors Update
Published on 08/22/2026 at 04:55, 1 day 11 hours ago Vanta Announces Closing of First Tranche of Private Placement and Board of Directors Update
Published on 08/22/2026 at 00:30, 1 day 15 hours ago BioNxt Solutions Inc. Announces Closing of Extension of Convertible Debentures and Issuance of Warrants
Published on 08/21/2026 at 23:00, 1 day 17 hours ago Tintina Mines Announces Voting Results from its Annual General and Special Meeting of Shareholders
Published on 08/21/2026 at 23:00, 1 day 17 hours ago Silver Storm Announces $7.5 Million Non-Brokered Private Placement with Eric Sprott
Published on 08/21/2026 at 19:36, 1 day 20 hours ago EQS-Adhoc: KAP AG ANNOUNCES CHANGE IN SHAREHOLDER STRUCTURE
Published on 08/21/2026 at 19:11, 1 day 20 hours ago EQS-Adhoc: Marley Spoon Group SE: Discussions with Misfits Market as permanent US fulfillment agent
Published on 08/21/2026 at 18:14, 1 day 21 hours ago Fuller, Smith & Turner PLC: Transaction in own shares
Published on 08/21/2026 at 17:27, 1 day 22 hours ago EQS-Adhoc: PSI Adjusts Its Forecast for Fiscal Year 2026 in Light of Economic Uncertainties in Europe
Published on 08/21/2026 at 16:30, 1 day 23 hours ago BL Networks (BLNWX) Details Major Global Infrastructure Expansion and Upgrades
Published on 08/18/2026 at 18:00, 4 days 22 hours ago KLARSEN : Nomonation Olivier Cornelis DG ITL et webinaire
Published on 08/18/2026 at 17:45, 4 days 22 hours ago Mise à disposition du rapport financier annuel 2025-26
